These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15497758)

  • 21. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency.
    Kazzaz J; Singh M; Ugozzoli M; Chesko J; Soenawan E; O'Hagan DT
    J Control Release; 2006 Feb; 110(3):566-73. PubMed ID: 16360956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diphtheria toxoid loaded poly-(epsilon-caprolactone) nanoparticles as mucosal vaccine delivery systems.
    Singh J; Pandit S; Bramwell VW; Alpar HO
    Methods; 2006 Feb; 38(2):96-105. PubMed ID: 16442811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against influenza virus infection by intranasal administration of hemagglutinin vaccine with chitin microparticles as an adjuvant.
    Hasegawa H; Ichinohe T; Strong P; Watanabe I; Ito S; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T
    J Med Virol; 2005 Jan; 75(1):130-6. PubMed ID: 15543590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Head-to-head comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model.
    Hagenaars N; Mastrobattista E; Glansbeek H; Heldens J; van den Bosch H; Schijns V; Betbeder D; Vromans H; Jiskoot W
    Vaccine; 2008 Dec; 26(51):6555-63. PubMed ID: 18848856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between antigen release and antibody response of infectious coryza water-in-oil-in-water emulsion vaccines.
    Fukanoki S; Matsumoto K; Mori H; Takeda R
    Avian Dis; 2000; 44(4):869-73. PubMed ID: 11195641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unique porous microspheres with dense core and a porous layer prepared by a novel S/O/W emulsion technique.
    Takai C; Hotta T; Shiozaki S; Boonsongrit Y; Abe H
    Chem Commun (Camb); 2009 Oct; (37):5533-5. PubMed ID: 19753347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional molecular mapping of a multiple emulsion by means of CARS microscopy.
    Meyer T; Akimov D; Tarcea N; Chatzipapadopoulos S; Muschiolik G; Kobow J; Schmitt M; Popp J
    J Phys Chem B; 2008 Feb; 112(5):1420-6. PubMed ID: 18197660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SEPPIC vaccine adjuvants for poultry.
    Dupuis L; Ascarateil S; Aucouturier J; Ganne V
    Ann N Y Acad Sci; 2006 Oct; 1081():202-5. PubMed ID: 17135512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzyme.
    Cheng MB; Wang JC; Li YH; Liu XY; Zhang X; Chen DW; Zhou SF; Zhang Q
    J Control Release; 2008 Jul; 129(1):41-8. PubMed ID: 18474405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.
    Simovic S; Heard P; Hui H; Song Y; Peddie F; Davey AK; Lewis A; Rades T; Prestidge CA
    Mol Pharm; 2009; 6(3):861-72. PubMed ID: 19358600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery.
    Sayin B; Somavarapu S; Li XW; Thanou M; Sesardic D; Alpar HO; Senel S
    Int J Pharm; 2008 Nov; 363(1-2):139-48. PubMed ID: 18662762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion.
    Baldwin SL; Shaverdian N; Goto Y; Duthie MS; Raman VS; Evers T; Mompoint F; Vedvick TS; Bertholet S; Coler RN; Reed SG
    Vaccine; 2009 Oct; 27(43):5956-63. PubMed ID: 19679214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthetic double-stranded RNA poly(I:C) combined with mucosal vaccine protects against influenza virus infection.
    Ichinohe T; Watanabe I; Ito S; Fujii H; Moriyama M; Tamura S; Takahashi H; Sawa H; Chiba J; Kurata T; Sata T; Hasegawa H
    J Virol; 2005 Mar; 79(5):2910-9. PubMed ID: 15709010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation of prospective plant oil derived micro-emulsion vehicles for drug delivery.
    Gupta S; Sanyal SK; Datta S; Moulik SP
    Indian J Biochem Biophys; 2006 Aug; 43(4):254-7. PubMed ID: 17133772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intramuscular absorption and biodistribution of dexamethasone from non-aqueous emulsions in the rat.
    Suitthimeathegorn O; Turton JA; Mizuuchi H; Florence AT
    Int J Pharm; 2007 Mar; 331(2):204-10. PubMed ID: 17250983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.